Testing before supplementing gives you a baseline to work from and lets you confirm, after 46 weeks, whether your levels have actually improved.
Clinical trials and our own patient experiences show that tirzepatide can help you achieve gradual, ongoing weight loss over several months
While nausea, vomiting, and diarrhea are the most commonly reported gastrointestinal adverse effects with GLP-1-based therapies (occurring in 15-40% of patients depending on the agent and dose), FDA prescribing information for several of these medications does list dyspepsia (indigestion) and, in some cases, gastroesophageal reflux disease (GERD) as reported adverse reactions
The final cost to patients depends on the type of insurance plan they have
Another study took place between September 2021 to late November 2022, in a total of 272 participants underwent adaptive randomization
Lyophilized in a cleanroom at our US facility